Enterostatin reduces serum cholesterol levels by way of a CCK(1) receptor-dependent mechanism |
| |
Authors: | Takenaka Yasuyuki Shimano Tomoko Mori Takaaki Hou I-Ching Ohinata Kousaku Yoshikawa Masaaki |
| |
Institution: | Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Gokasho Uji, Kyoto 611-0011, Japan. |
| |
Abstract: | Enterostatin (APGPR), an anorectic pentapeptide derived from the amino terminus of procolipase, significantly reduced serum cholesterol levels after oral administration at a dose of 100 mg/kg for 3 days in mice fed a high-cholesterol-cholic acid diet. The hypocholesterolemic effect of APGPR was inhibited by pretreatment with lorglumide, an antagonist for cholecystokinin 1 (CCK(1)) receptor, even though APGPR does not have any affinity for CCK(1) receptors. Similarly, the hypocholesterolemic activity of VPDPR, an APGPR analogue, was blocked by lorglumide. These results suggest that the hypocholesterolemic effects of APGPR and VPDPR are mediated by a CCK(1) receptor-dependent mechanism. |
| |
Keywords: | Enterostatin APGPR VPDPR Hypocholesterolemic effect CCK1 receptor |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|